IFNG and Parkinson disease: While one small study reports increased plasma levels of IFN-γ, IL-1β, IL-2 and TNF-α in eight PD patients24, two larger studies did not find any differences in blood and CSF levels between PD patients and healthy individuals with vs. without heterozygous GBA mutations25,26.